Glaukos Statistics
NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD
172.18+10.59 (+6.55%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Glaukos by the numbers
Glaukos has a market capitalization of $10.16 billion based on 58.98M shares outstanding. With trailing EPS of $-3.26, Glaukos is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.1% below its 50-day average and 27.0% above its 200-day average.
Average daily trading volume is 791.91K shares, or about $136.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GKOS valuation vs. peer median
| Metric | GKOS | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.16B | $9.61B | +6% |
| Forward P/E | 328.9 | 15.5 | +2019% |
| Avg. volume | 791.91K | 1.26M | -37% |
Peer median across 8 companies: GMED, PODD, BAX, PEN, SOLV, MMED, STVN, TFX.
Valuation
- Market cap
- $10.16B
- Forward P/E
- 328.86
- Price / sales (latest FY)
- 20.01
- EPS (TTM)
- $-3.26
- Shares outstanding
- 58.98M
Price and trading
- Previous close
- 161.59
- Open
- 161.00
- Day range
- 159.59 – 174.48
- 52-week range
- 73.16 – 191.62
- 52-week change
- +104.76%
- 50-day moving average
- 172.39
- 200-day moving average
- 135.53
- Beta
- —
- Volume
- 1.41M
- Average volume
- 791.91K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 10.16B
- Forward Pe
- 328.86
- Eps
- -3.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 191.62
- Week52 Low
- 73.16
- Avg Volume
- 791.91K
- Shares Outstanding
- 58.98M
- Ma50
- 172.39
- Ma200
- 135.53
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -10.15%
- Pct From52w Low
- 135.35%